Vimarsana
Biggest News Aggregation in the World

Page 6 - Prognostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prognostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prognostics Inc Today - Breaking & Trending Today

SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX - Vimarsana News

SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations - Vimarsana News

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations - Vimarsana News

Sera Prognostics Announces Publication Of Data Confirming The Performance Of The IBP4/SHBG Biomarkers In Diverse Non-U.S. Populations

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs - Vimarsana News

Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sera Prognostics Announces Publication of the Clinical Validation of PreTRM® Threshold for Clinical Action - Vimarsana News

Sera Prognostics Announces Publication of the Clinical Validation of PreTRM® Threshold for Clinical Action

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...